ANVS
Annovis Bio, Inc.
Latest Form 4:Purchase$143KbyHoffman Michael B (Director) · filed May 22, 2026
Annovis Bio, Inc. (ANVS) has 3 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 22, 2026.
The most active filer is Director Hoffman Michael B with 3 filings. Insiders have net bought $1.8M over the trailing 6 months. The largest single insider purchase in this window was $1.5M by Director Hoffman Michael B on Apr 2, 2026.
- Industry:Biotechnology
- CEO:Maria L. Maccecchini
- Employees:8
- HQ:Malvern, PA, US
- IPO:2020-01-29
Insider Buying
$1.8M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$64.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 76,344 | $143K | May 22 | SEC ↗ | |
Hoffman Michael BFirst in 4 months | Director | Purchase | 713,800 | $1.5M | Apr 3 | SEC ↗ |
Hoffman Michael BFirst filing | Director | Purchase | 45,000 | $194K | Dec 8 | SEC ↗ |
Related companies
Annovis Bio, Inc. is in the Healthcare sector.